Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Fujirebio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Neurology
Quick Facts
HQ:Belgium
Founded:2012
Employees:850
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval YV91X9
PMDA · #APR-OB4ZZ3FF · 2022-01-01
Drug Approval G4QVO8
PMDA · #APR-OB4JV744 · 2022-12-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-7GH6OD5Z
Issued: 2020-11-16
Expires: 2025-05-15
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-Z2CHSAIF
Issued: 2020-06-08
Expires: 2025-01-23
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-PWQE7NX2
Issued: 2020-09-20
Expires: 2025-08-05
WHO GMP
World Health Organization
Cert #: CERT-NFEM5C02
Issued: 2020-08-18
Expires: 2025-04-01
Loading CDMO intelligence...
Key facts about Fujirebio
- Fujirebio is headquartered in Belgium.
- Fujirebio was founded in 2012.
- Fujirebio has 850 employees.
- Fujirebio's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Fujirebio
Directory pages this company appears in, each with the full list of matching manufacturers.